Stonepine Capital Management as of March 31, 2017
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 21 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Recro Pharma | 14.2 | $25M | 2.9M | 8.74 | |
| Viveve Med | 13.7 | $24M | 3.8M | 6.30 | |
| Noveliontherapeuti.. | 9.4 | $17M | 1.6M | 10.74 | |
| SciClone Pharmaceuticals | 9.2 | $16M | 1.7M | 9.80 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 7.5 | $13M | 17M | 0.80 | |
| Ophthotech | 7.2 | $13M | 3.5M | 3.66 | |
| Alere | 6.2 | $11M | 275k | 39.73 | |
| Vericel (VCEL) | 5.2 | $9.1M | 3.3M | 2.80 | |
| Cardiome Pharma | 4.7 | $8.3M | 2.8M | 3.01 | |
| Flamel Technologies Sa | 4.1 | $7.3M | 752k | 9.68 | |
| Enanta Pharmaceuticals (ENTA) | 3.2 | $5.7M | 185k | 30.80 | |
| BioDelivery Sciences International | 3.0 | $5.4M | 2.8M | 1.90 | |
| Veracyte (VCYT) | 3.0 | $5.3M | 578k | 9.18 | |
| Cumberland Pharmaceuticals (CPIX) | 2.9 | $5.1M | 740k | 6.94 | |
| Alimera Sciences | 2.0 | $3.6M | 2.6M | 1.40 | |
| DURECT Corporation | 1.7 | $2.9M | 2.8M | 1.05 | |
| Trinity Biotech | 1.2 | $2.1M | 352k | 5.96 | |
| Emergent BioSolutions (EBS) | 0.9 | $1.6M | 55k | 29.04 | |
| Xoma Corp Del (XOMA) | 0.3 | $625k | 88k | 7.11 | |
| Vanda Pharmaceuticals (VNDA) | 0.3 | $606k | 43k | 14.00 | |
| Aviragen Therapeutics | 0.1 | $204k | 314k | 0.65 |
